Cargando…
ACE2 and a Traditional Chinese Medicine Formula NRICM101 Could Alleviate the Inflammation and Pathogenic Process of Acute Lung Injury
COVID-19 is a highly transmittable respiratory illness caused by SARS-CoV-2, and acute lung injury (ALI) is the major complication of COVID-19. The challenge in studying SARS-CoV-2 pathogenicity is the limited availability of animal models. Therefore, it is necessary to establish animal models that...
Autores principales: | Lin, Cheng-Han, Chen, Yi-Ju, Lin, Meng-Wei, Chang, Ho-Ju, Yang, Xin-Rui, Lin, Chih-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533189/ https://www.ncbi.nlm.nih.gov/pubmed/37763673 http://dx.doi.org/10.3390/medicina59091554 |
Ejemplares similares
-
Treating COVID-19 with NRICM101 and NRICM102 – Author’s reply
por: Lin, Sunny Jui-Shan, et al.
Publicado: (2022) -
Treating COVID-19 with NRICM101 and NRICM102 – Author’s reply 3
por: Tseng, Yu-Hwei, et al.
Publicado: (2022) -
Treating COVID-19 with NRICM101 and NRICM102 – Author’s reply 2
por: Lee, Ming-Yung, et al.
Publicado: (2022) -
The development and application of NRICM101 and NRICM102 for the treatment of COVID-19
por: Ho, Shung-Tai, et al.
Publicado: (2023) -
A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study
por: Tsai, Keng-Chang, et al.
Publicado: (2021)